porcin
reproduct
respiratori
syndrom
prr
character
respiratori
diseas
neonat
grow
pig
reproduct
failur
gilt
sow
increas
number
abort
mummifi
foetus
stillbirth
weakborn
piglet
prr
consid
one
econom
import
swine
infecti
diseas
around
world
estim
loss
million
annual
usa
alon
prr
viru
prrsv
classifi
two
genotyp
type
european
type
north
american
addit
high
degre
genet
variat
genotyp
found
divid
subtyp
paneuropean
subtyp
east
european
subtyp
possibl
fourth
subtyp
suggest
signific
differ
virul
also
describ
subtyp
east
european
subtyp
seemingli
compris
virul
strain
prrsv
show
mark
tropism
cell
monocytemacrophag
lineag
main
target
prrsv
alveolar
tissu
macrophag
lesser
extent
monocyt
dendrit
cell
absent
weak
interferon
alpha
secret
consequ
weak
delay
cellmedi
immun
respons
low
level
describ
follow
prrsv
infect
pig
infect
prrsv
also
shown
delay
product
neutral
antibodi
prrsv
replic
report
lymphoid
organ
howev
studi
also
shown
lack
homogen
proinflammatori
cytokin
respons
suggest
role
tissu
pathogenesi
prr
also
highlight
need
compar
vivo
studi
use
strain
differ
virul
porcin
lymph
node
ln
dens
medulla
cell
predomin
lack
sinus
cord
ln
cortex
divid
two
differenti
area
follicl
f
interfollicular
area
f
b
cell
rich
area
also
contain
follicular
dendrit
cell
fdc
helper
cell
collabor
antigen
present
b
cell
subsequ
antibodi
product
area
rich
cell
propos
immunopathogenesi
porcin
circoviru
infect
associ
follicular
chang
lymph
node
suggest
could
also
case
prrsv
infect
transcript
express
profil
studi
aid
understand
infect
biolog
molecular
basi
diseas
sever
studi
analys
host
transcript
profil
prrsv
infect
differ
organ
take
small
piec
tissu
none
address
transcript
profil
defin
tissu
structur
laser
captur
microdissect
lcm
power
tool
acquisit
homogen
cell
popul
specif
tissu
structur
analyz
varieti
molecular
biolog
techniqu
aid
diseas
pathogenesi
investig
main
aim
studi
compar
cytokin
transcript
profil
differ
compart
lymph
node
pig
infect
three
strain
defin
virul
studi
includ
prototyp
lelystad
viru
lv
field
strain
uk
categor
low
virul
subtyp
virus
diverg
highli
pathogen
eastern
european
subtyp
strain
belaru
use
lcm
follow
quantit
revers
transcriptas
pcr
rtqpcr
viral
rna
cytokin
transcript
measur
f
area
mediastin
lymph
node
medln
collect
select
timepoint
postinfect
contextu
data
cell
b
cell
macrophag
immunolabel
character
cell
popul
within
lymph
node
compart
three
strain
use
studi
lvter
huurn
select
prototyp
subtyp
strain
kindli
provid
ann
mari
rebel
cvi
lelystad
netherland
subtyp
strain
isol
serum
postwean
piglet
show
sign
wast
poor
condit
farm
england
isol
anim
plant
health
agenc
apha
addleston
uk
highli
pathogen
subtyp
strain
isol
apha
lung
tissu
pig
belaru
kindli
provid
dr
tomasz
stadejek
warsaw
univers
life
scienc
poland
also
includ
viru
propag
carri
previous
describ
seventysix
specificpathogenfre
fiveweekold
male
piglet
prrsv
seroneg
farm
netherland
use
studi
anim
match
weight
randomli
alloc
four
group
control
group
anim
alloc
wherea
infect
group
anim
use
group
hous
separ
room
allow
free
airflow
outsid
allow
acclimatis
day
prior
experi
measur
taken
prevent
crosscontamin
group
includ
chang
cloth
equip
room
seven
week
age
group
piglet
inocul
intranas
ml
complet
roswel
park
memori
institut
medium
supplement
fb
crpmi
contain
tissuecultur
infect
dose
strain
lv
respect
remain
control
group
inocul
intranas
ml
uninfect
porcin
alveolar
macrophag
cryolys
crpmi
four
anim
control
group
five
virusinocul
group
euthan
day
postinfect
dpi
remain
anim
euthan
dpi
experi
perform
accord
anim
scientif
procedur
act
uk
follow
approv
apha
ethic
review
committe
clinic
score
system
predefin
human
endpoint
use
prevent
undu
suffer
pig
monitor
daili
throughout
studi
clinic
sign
includ
rectal
temperatur
score
record
previous
describ
medln
main
drain
lymph
node
apic
medial
lobe
lung
sinc
prrsv
frequent
detect
lung
lobe
medln
select
studi
gross
patholog
evalu
postmortem
examin
analysi
rtqpcr
piec
mm
medln
embed
cryopreserv
optim
cut
temperatur
oct
compound
sakura
finetek
europ
bv
nederland
previous
describ
histopatholog
examin
remain
medln
sampl
fix
buffer
formalin
routin
process
embed
paraffinwax
tissu
section
stain
haematoxylin
eosin
histopatholog
lesion
evalu
slide
use
light
microscop
immunolabel
cell
marker
done
use
avidinbiotin
complex
method
abc
vector
elit
vector
laboratori
usa
describ
previous
briefli
thick
section
dewax
rehydr
follow
endogen
peroxidas
inhibit
methanol
min
depend
epitop
interest
antigen
retriev
tissu
section
perform
enzymat
trypsinalphachymotrypsin
microwav
section
citric
acid
citrat
buffer
prrsv
nucleocapsid
n
protein
slide
mount
sequenza
immunostain
centr
shandon
scientif
uk
wash
tri
buffer
salin
tb
ph
uk
incub
min
room
temperatur
per
slide
block
solut
primari
antibodi
use
monoclon
antihuman
dako
uk
monoclon
antihuman
dako
uk
monoclon
antihuman
abdserotec
uk
antibodi
appli
h
room
temperatur
case
correspond
biotinyl
secondari
antibodi
vector
laboratori
uk
incub
min
room
temperatur
slide
incub
min
avidinbiotin
complex
label
perform
use
tetrahydrochlorid
dab
sigmaaldrich
uk
section
counterstain
mayer
haematoxylin
dehydr
mount
posit
neg
control
well
isotyp
control
includ
ihc
run
immunolabel
medln
section
examin
light
microscopi
immunolabel
measur
record
use
score
rank
cellular
deplet
cellular
increment
compar
control
group
posit
scale
absenc
posit
cellstructur
scarc
posit
cellsstructur
mildmoder
posit
cellsstructur
abund
posit
cellsstructur
neg
scale
absenc
differ
control
group
scarc
less
posit
cell
compar
control
group
mildmoder
less
posit
cell
compar
control
group
abund
less
posit
cell
compar
control
group
frozen
octembed
medlnswer
cut
thick
section
use
cryostat
tissu
section
place
membraneco
slide
penmembran
leica
microsystem
germani
cryostat
treat
rnazap
solut
life
technolog
uk
sampl
order
avoid
crosscontamin
rna
section
airdri
fix
ethanol
min
stain
rnase
free
haematoxylin
min
two
consecut
medln
tissu
section
use
per
anim
observ
f
peripher
dissect
captur
separ
rnasefre
pcr
tube
greiner
bioon
uk
use
laser
microdissector
leica
leica
germani
sampl
immedi
frozen
store
laboratori
process
sampl
total
rna
extract
use
rna
queousmicro
kit
ambion
life
technolog
uk
follow
manufactur
instruct
lcm
sampl
includ
dnase
treatment
dnase
inactiv
step
total
rna
quantifi
use
qubit
fluoromet
life
technolog
sampl
adjust
rna
concentr
prrsv
infect
kinet
f
area
medln
studi
measur
viral
rna
prrsv
rtqpcr
perform
previous
describ
briefli
sampl
standard
rna
dilut
ad
templat
quantitec
probe
rtpcr
kit
qiagen
uk
follow
manufactur
instruct
total
volum
data
analys
chang
cycl
threshold
ct
result
calcul
ct
repres
differ
last
cycl
prrsv
rtqpcr
ct
sampl
primer
taqman
probe
set
porcin
cytokin
synthes
sigmaaldrich
tabl
cytokin
primer
pair
produc
amplicon
smaller
base
pair
bp
primer
probe
set
optim
laboratori
condit
order
obtain
complementari
dna
cdna
revers
transcript
carri
use
superscript
vilotm
cdna
synthesi
kit
appli
biosystem
uk
cdna
store
laboratori
process
cdna
dilut
rnase
free
water
use
templat
cytokin
qpcr
use
express
qpcr
supermix
invitrogen
rox
refer
dye
total
volum
thermal
cycl
condit
min
cycl
denatur
annealingextens
min
revers
transcript
neg
control
nontempl
control
includ
pcr
plate
centrifug
prior
amplif
use
strategen
qpcr
system
stratagen
uk
foldchang
cytokin
express
calcul
use
method
use
endogen
calibr
select
due
stabl
express
porcin
lymphat
tissu
rel
gene
express
result
present
base
logarithm
scale
statist
analys
perform
use
spss
softwar
spss
inc
usa
graph
prepar
use
spss
softwar
spss
inc
usa
graphpad
prism
graphpad
softwar
inc
usa
determin
nonnorm
distribut
data
kolmogorovsmirnov
test
use
nonnorm
distribut
data
analys
use
nonparametr
test
kruskalw
test
perform
analys
mean
paramet
prrsv
rna
load
immunolabel
cell
cytokin
express
anim
group
control
lv
three
differ
timepoint
post
inocul
dpi
dpi
dpi
thereaft
perform
multipl
comparison
use
nonparametr
test
bonferroni
correct
posthoc
determin
signific
individu
differ
final
presenc
differ
result
obtain
f
tissu
assess
use
nonparametr
wilcoxon
signedrank
test
correl
prrsv
rna
cytokin
transcript
determin
spearman
rho
analysi
p
valu
less
consid
signific
rectal
temperatur
remain
within
physiolog
rang
control
well
infect
anim
except
infect
anim
show
hyperthermia
dpi
infect
anim
develop
elev
clinic
sign
score
mean
score
compar
rest
anim
studi
mean
clinic
score
macroscop
postmortem
mild
moder
enlarg
medln
observ
infect
anim
dpi
dpi
medln
damag
observ
control
anim
show
lesion
studi
histopatholog
analysi
medln
reveal
presenc
lymphoid
follicl
mild
hypertrophi
germin
centr
presenc
apoptot
bodi
dpi
dpi
virusinfect
group
show
signific
histolog
lesion
prrsv
rna
measur
shown
figur
prrsv
infect
anim
show
higher
prrsv
rna
load
dpi
dpi
p
viral
rna
detect
control
anim
data
shown
lv
group
show
dpi
higher
viral
rna
area
medln
ct
sd
p
dpi
viral
rna
amount
similar
medln
compart
sd
ct
sd
f
area
respect
dpi
lv
rna
significantli
reduc
medln
compart
ct
ct
f
area
respect
p
figur
rna
detect
dpi
mainli
area
medln
ct
p
dpi
rna
increas
highest
level
seen
studi
group
higher
area
f
ct
ct
respect
p
interestingli
viru
detect
f
medln
dpi
ct
p
figur
dpi
rna
mostli
detect
ct
p
wherea
dpi
rna
mostli
found
f
ct
p
dpi
rna
decreas
statist
signific
medln
compart
although
predominantli
detect
f
medln
ct
p
figur
group
show
higher
load
viral
rna
medln
compart
timepoint
throughout
studi
figur
p
dpi
prrsv
rna
mainli
detect
area
figur
rna
amount
statist
signific
lower
lv
group
p
prrsv
rna
remain
higher
compart
dpi
lv
group
higher
f
pig
p
figur
dpi
rna
f
statist
signific
higher
lv
infect
group
p
group
signific
higher
f
medln
infect
anim
p
figur
immunolabel
defin
cell
popul
locat
medln
studi
number
cell
found
increas
f
medln
dpi
infect
anim
compar
control
anim
semiquantit
immunolabel
cell
sqic
lv
group
sqic
group
p
dpi
follicular
cell
popul
remain
statist
higher
lv
infect
anim
sqic
lv
p
figur
convers
number
cell
decreas
medln
dpi
lv
sqic
p
inocul
anim
sqic
p
remain
lower
control
anim
dpi
infect
anim
sqic
lv
sqic
p
figur
immunolabel
panb
cell
surfac
protein
show
b
cell
f
medln
infect
anim
cell
decreas
number
compar
control
anim
dpi
sqic
lv
sqic
group
p
dpi
sqic
lvand
sqic
group
p
dpi
b
cell
popul
show
statist
signific
chang
infect
control
group
figur
macrophag
identifi
imunolabel
medln
section
f
macrophag
number
found
statist
increas
infect
anim
dpi
sqic
day
p
area
infect
anim
macrophag
popul
increas
timepoint
sqic
p
howev
anim
inocul
lv
prrsv
strain
show
smaller
increas
macrophag
area
dpi
sqic
p
figur
repres
imag
ihc
stain
group
shown
figur
assess
immun
respons
select
strain
within
differ
medln
compart
transcript
level
measur
rtqpcr
compar
control
anim
figur
suitabl
rna
qualiti
confirm
test
express
sampl
cdna
sampl
produc
posit
amplif
gene
qpcr
compar
control
anim
studi
ln
compart
gener
downregul
infect
group
timepoint
statist
signific
strain
dpi
p
group
show
lowest
transcript
level
remain
downregul
dpi
medln
infect
pig
p
figur
express
downregul
area
medln
lv
infect
pig
dpi
p
medln
group
dpi
p
figur
compar
control
group
significantli
upregul
f
medln
lv
p
infect
pig
p
hand
signific
downregul
area
medln
infect
anim
dpi
p
figur
dpi
statist
signific
upregul
f
infect
group
p
figur
signific
differ
express
mrna
detect
studi
data
shown
transcript
level
statist
significantli
regul
infect
group
first
week
experi
howev
dpi
transcript
level
increas
area
medln
anim
group
p
figur
dpi
gene
express
significantli
downregul
f
group
p
area
p
group
contrast
significantli
upregul
area
medln
lv
infect
group
p
figur
statist
significantli
downregul
dpi
area
medln
infect
anim
p
dpi
medln
group
p
dpi
area
medln
infect
pig
p
contrari
statist
upregul
f
lv
group
dpi
p
figur
statist
signific
correl
gene
express
immun
gene
medln
compart
lv
prrsv
rna
respect
repres
tabl
studi
reveal
addit
data
gener
anim
experi
conduct
apha
part
eu
porrscon
project
studi
conceiv
directli
compar
modul
immun
respons
transcript
defin
medln
compart
pig
experiment
infect
strain
vari
virul
pig
infect
prrsv
strain
shown
greater
medln
gross
patholog
compar
paneuropean
subtyp
strain
lv
present
studi
highest
prrsv
rna
level
detect
area
medln
suggest
prrsv
enter
apic
medial
lung
lobe
medln
via
drain
lymphat
vessel
previous
shown
prrsv
infect
group
viru
load
serum
show
peak
dpi
decreas
dpi
wherea
bronchoalveolar
lavag
fluid
balf
viru
persist
dpi
interestingli
despit
enhanc
virul
level
viru
circul
balf
lowest
infect
anim
contrast
present
analysi
detect
higher
level
medln
compar
subtyp
strain
suggest
subtyp
strainmay
infect
ln
residenttransi
cell
popul
effici
could
link
higher
pathogen
strain
support
data
prrsv
n
protein
detect
ihc
mainli
cytoplasm
macrophag
medln
infect
pig
dpi
highest
level
immunolabel
cell
found
infect
anim
use
lmd
present
studi
enabl
first
time
measur
rna
within
differ
medln
compart
result
show
presenc
prrsv
f
medln
dpi
albeit
low
level
accord
previou
report
describ
detect
infecti
prrsv
lymphoid
tissu
sever
month
hypothes
prrsv
may
interact
fdc
secondari
lymph
organ
medln
could
impair
fdc
present
prrsv
antigen
b
cell
could
contribut
lack
product
neutral
antibodi
detect
prrsv
infect
studi
prrsv
presenc
follicl
medln
nonneutr
ab
secret
dpi
suggest
role
fdc
immunopathogenesi
prrsv
b
cell
deplet
observ
f
area
medln
studi
accord
previou
report
show
b
cell
deplet
cortic
area
secondari
lymph
organ
thymu
lymph
node
prrsv
infect
pig
immun
cell
deplet
lymphoid
tissu
recent
associ
apoptot
cell
death
indirectli
induc
bystand
cell
prrsv
infect
cell
show
cell
increas
f
mostli
dpi
could
relat
migrat
helper
cell
f
area
assist
induct
b
cell
respons
studi
macrophag
popul
increas
medln
especi
group
indic
strain
induc
higher
inflammatori
respons
lung
strain
test
accord
previou
report
product
type
ifn
critic
activ
innat
immun
respons
viral
infect
well
regul
induct
adapt
immun
respons
detect
either
chang
lower
transcript
level
prrsv
inocul
group
notic
dpi
like
play
role
delay
onset
effect
innat
immun
respons
show
prrsv
reduc
transcript
would
also
impair
innat
immun
respons
delay
adapt
immun
respons
interestingli
gene
express
posit
correl
lv
infect
pig
lv
rna
level
neg
correl
gene
express
rna
level
neg
correl
gene
express
result
suggest
prrsv
downregul
cytokin
gene
induct
site
infect
agreement
previou
studi
result
also
support
hypothesi
subtyp
strain
develop
effici
strategi
avoid
host
immun
respons
among
genotyp
virus
upregul
express
dpi
evid
delay
adapt
immun
respons
prrsv
inocul
group
previous
describ
studi
posit
correl
gene
express
prrsv
lv
strain
suggest
subtyp
induct
express
depend
directli
presenc
viru
describ
soc
protein
pivot
regul
innat
adapt
immun
respons
specif
act
neg
regul
signal
inhibit
activ
therebi
express
mediat
gene
induct
prrsv
vaccinatedinfect
pig
describ
suggest
express
infect
cell
may
mechan
evad
host
immun
respons
nevertheless
posit
correl
gene
express
lv
group
could
result
neg
feedback
control
system
addit
vitro
experi
may
use
elucid
propos
induct
prrsv
initi
phase
viru
infect
protein
heterodim
secret
antigen
present
cell
macrophag
dc
cytokin
necessari
differenti
surviv
cell
induc
proinflammatori
reaction
secret
studi
detect
transcript
could
explain
transcript
kinet
cytokin
earlier
later
compar
tissu
sampl
collect
point
limit
factor
produc
biolog
activ
protein
secret
absenc
chain
induct
typic
lower
present
studi
upregul
dpi
statist
signific
dpi
f
prrsv
group
suggest
prrsv
may
modul
cytokin
environ
drive
differenti
oppos
antivir
cell
transcript
level
show
consider
variat
prrsv
strain
previous
describ
therefor
studi
support
idea
induct
mechan
delay
host
immun
respons
common
strategi
among
genotyp
gene
express
either
unaffect
downregul
agreement
previou
find
may
explain
posit
correl
cytokin
detect
studi
standard
techniqu
use
take
sampl
mrna
extract
select
differ
tissu
structur
way
lmc
therefor
conclud
lmc
combin
rtqpcr
power
tool
enabl
differenti
transcriptom
profil
differ
medln
compart
infect
pig
studi
show
sever
exampl
demonstr
immunopathogenesi
infect
associ
site
infect
instanc
show
higher
tissu
pathogenesi
virul
compar
subtyp
strain
also
provid
evid
strain
avoid
innat
immun
respons
infect
pig
downregul
f
area
medln
induc
b
cell
deplet
cortex
medln
